Literature DB >> 24037712

Chloride channels in myotonia congenita assessed by velocity recovery cycles.

S Veronica Tan1, Werner J Z'Graggen, Delphine Boërio, Dipa Raja Rayan, Fiona Norwood, Deborah Ruddy, R Howard, Michael G Hanna, Hugh Bostock.   

Abstract

INTRODUCTION: Myotonia congenita (MC) is caused by congenital defects in the muscle chloride channel CLC-1. This study used muscle velocity recovery cycles (MVRCs) to investigate how membrane function is affected.
METHODS: MVRCs and responses to repetitive stimulation were compared between 18 patients with genetically confirmed MC (13 recessive, 7 dominant) and 30 age-matched, normal controls.
RESULTS: MC patients exhibited increased early supernormality, but this was prevented by treatment with sodium channel blockers. After multiple conditioning stimuli, late supernormality was enhanced in all MC patients, indicating delayed repolarization. These abnormalities were similar between the MC subtypes, but recessive patients showed a greater drop in amplitude during repetitive stimulation.
CONCLUSIONS: MVRCs indicate that chloride conductance only becomes important when muscle fibers are depolarized. The differential responses to repetitive stimulation suggest that, in dominant MC, the affected chloride channels are activated by strong depolarization, consistent with a positive shift of the CLC-1 activation curve.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  chloride channels; muscle membrane potential; muscle velocity recovery cycle; myotonia congenita; tibialis anterior muscle

Mesh:

Substances:

Year:  2014        PMID: 24037712     DOI: 10.1002/mus.24069

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  In vivo assessment of muscle membrane properties in the sodium channel myotonias.

Authors:  S Veronica Tan; Werner J Z'Graggen; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2017-09-23       Impact factor: 3.217

2.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

3.  Co-occurrence of DMPK expansion and CLCN1 mutation in a patient with myotonia.

Authors:  Sara Locci; Rosanna Cardani; Paola Brunori; Sabrina Lucchiari; Giacomo P Comi; Antonio Federico; Nicola De Stefano; Giovanni Meola; Andrea Mignarri
Journal:  Neurol Sci       Date:  2021-08-13       Impact factor: 3.307

4.  Association of Three Different Mutations in the CLCN1 Gene Modulating the Phenotype in a Consanguineous Family with Myotonia Congenita.

Authors:  Lucas Santos Souza; Priscila Calyjur; Antonio Fernando Ribeiro; Juliana Gurgel-Giannetti; Rita Cassia Mingroni Pavanello; Mayana Zatz; Mariz Vainzof
Journal:  J Mol Neurosci       Date:  2021-01-19       Impact factor: 3.444

5.  Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation.

Authors:  Michael G Thor; Vinojini Vivekanandam; Marisol Sampedro-Castañeda; S Veronica Tan; Karen Suetterlin; Richa Sud; Siobhan Durran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna; Emma Matthews; Roope Männikkö
Journal:  Sci Rep       Date:  2019-11-26       Impact factor: 4.379

6.  Ageing contributes to phenotype transition in a mouse model of periodic paralysis.

Authors:  Karen J Suetterlin; S Veronica Tan; Roope Mannikko; Rahul Phadke; Michael Orford; Simon Eaton; Avan A Sayer; Miranda D Grounds; Emma Matthews; Linda Greensmith; Michael G Hanna
Journal:  JCSM Rapid Commun       Date:  2021-05-05

7.  Leg pain in neuropathic postural tachycardia syndrome is associated with altered muscle membrane properties.

Authors:  Belén Rodriguez; Karin Jost; Lotte Hardbo Larsen; Hatice Tankisi; Werner J Z'Graggen
Journal:  Clin Auton Res       Date:  2021-10-21       Impact factor: 4.435

Review 8.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.